Department of Nuclear Medicine, Imperial College Healthcare, Hammersmith Hospital, London, UK.
Eur J Radiol. 2010 Mar;73(3):504-9. doi: 10.1016/j.ejrad.2010.01.021. Epub 2010 Feb 20.
to investigate the role of FDG-PET and PET/CT in the evaluation of vasculitis.
a systematic revision of the papers published in PubMed/Medline until December 2009 was done.
FDG-PET and PET/CT have been proven to be valuable in the diagnosis of large-vessel vasculitis, especially giant cells arteritis with sensitivity values ranging 77% to 92%, and specificity values ranging 89% to 100%. In particular, FDG-PET/CT has demonstrated the potential to non-invasively diagnose the onset of the vasculitis earlier than traditional anatomical imaging techniques, thus enabling prompt treatment. False positive results mainly occur in the differential diagnosis between vasculitis and atherosclerotic vessels in elderly patients. Another area where FDG-PET/CT is gaining wider acceptance is in monitoring response to therapy; it can reliably detect the earliest changes of disease improvement post-therapy, and persistent activity is an indicator of non-responders to therapy. A few data have been reported about medium/small vessel vasculitis.
FDG-PET and PET/CT have proven utility: (a) in the initial diagnosis of patients suspected of having vasculitis particularly in those who present with non-specific symptoms; (b) in the identification of areas of increased FDG uptake in which a biopsy should be done for obtaining a diagnosis; (c) in evaluating the extent of the disease; (d) in assessing response to treatment.
研究 FDG-PET 和 PET/CT 在血管炎评估中的作用。
对 2009 年 12 月以前在 PubMed/Medline 上发表的论文进行了系统回顾。
FDG-PET 和 PET/CT 已被证明对大血管血管炎,尤其是巨细胞动脉炎的诊断具有重要价值,其灵敏度值为 77%至 92%,特异性值为 89%至 100%。特别是 FDG-PET/CT 具有潜在的能力,可在传统解剖成像技术之前更早地非侵入性诊断血管炎的发病,从而实现及时治疗。假阳性结果主要发生在血管炎与老年患者的动脉粥样硬化血管之间的鉴别诊断中。FDG-PET/CT 另一个得到更广泛认可的领域是监测治疗反应;它能够可靠地检测治疗后疾病改善的最早变化,持续的活性是对治疗无反应的指标。已有一些关于中/小血管血管炎的报告。
FDG-PET 和 PET/CT 已被证明具有以下用途:(a)在疑似患有血管炎的患者的初始诊断中,特别是在出现非特异性症状的患者中;(b)在识别 FDG 摄取增加的区域,这些区域应进行活检以获得诊断;(c)评估疾病的范围;(d)评估对治疗的反应。